Table 3 Antimalarial treatments for children with uncomplicated malaria presenting to health facilities with artemether-lumefantrine in stock – change of practice between 2004 and 2006 surveys in four districts in Zambia
2004 | 5–9 kg (N = 254) | = 10 kg (N = 192) | ||
|---|---|---|---|---|
No (%) | 95% CI* | No (%) | 95% CI* | |
Artemether-lumefantrine | 6 (2.4) | 0, 5.7 | 42 (21.9) | 12.4, 31.3 |
Sulphadoxine-pyrimethamine | 183 (72.1) | 61.0, 83.1 | 103 (53.7) | 39.7, 67.6 |
Quinine | 9 (3.5) | 0.3, 6.8 | 6 (3.1) | 0.4, 5.9 |
No antimalarial prescribed | 56 (22.1) | 11.6, 32.5 | 41 (21.4) | 12.7, 30.0 |
2006 | 5–9 kg (N = 351) | ≥ 10 kg (N = 374) | ||
No (%) | 95% CI* | No (%) | 95% CI* | |
Artemether-lumefantrine | 144 (41.0) | 31.5, 50.5 | 219 (58.6) | 50.2, 66.9 |
Sulphadoxine-pyrimethamine | 77 (21.9) | 15.4, 28.5 | 51 (13.6) | 7.1, 20.2 |
Quinine | 8 (2.3) | 0.1, 4.5 | 14 (3.7) | 0, 7.9 |
No antimalarial prescribed | 122 (34.8) | 27.2, 42.3 | 90 (24.1) | 17.4, 30.7 |